Necrostatin-1

CAS No. 4311-88-0

Necrostatin-1( Nec-1 )

Catalog No. M14462 CAS No. 4311-88-0

Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 46 In Stock
5MG 29 In Stock
10MG 43 In Stock
25MG 71 In Stock
50MG 107 In Stock
100MG 166 In Stock
200MG 245 In Stock
500MG 411 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Necrostatin-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM.
  • Description
    Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Nec-1
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    RIP1
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    4311-88-0
  • Formula Weight
    259.33
  • Molecular Formula
    C13H13N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 51 mg/mL warmed (196.66 mM)
  • SMILES
    O=C(C(CC1=CNC2=C1C=CC=C2)N3)N(C)C3=S
  • Chemical Name
    5-(1H-indol-3-ylmethyl)-3-methyl-2-thioxo-4-imidazolidinone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Han W, et al. Apoptosis. 2009 May;14(5):674-86.
molnova catalog
related products
  • Atibuclimab

    Atibuclimab is a chimeric monoclonal antibody targeting CD14, consisting of a mouse variable region and a human IgG4 Fc region.

  • Physcion 8-O-β-D-glu...

    Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.

  • Armepavine

    Armepavine exerted both in vitro and in vivo antifibrotic effects in rats, with inhibition of NF-κB, JunD and C/EBP? pathways.